XML 33 R23.htm IDEA: XBRL DOCUMENT v3.25.3
Stock-based compensation (Tables)
9 Months Ended
Sep. 30, 2025
Share-Based Payment Arrangement [Abstract]  
Schedule of stock-based compensation expense

    

Three Months Ended September 30, 

    

Nine Months Ended September 30, 

2025

    

2024

2025

2024

Stock options

$

1,402

$

1,316

$

3,941

$

2,903

Restricted stock units

 

286

 

230

 

817

 

851

Total stock-based compensation expense

$

1,688

$

1,546

$

4,758

$

3,754

Included in:

General and administrative expense

$

1,454

$

1,311

$

4,068

$

3,005

Research and development expense

 

234

 

235

 

690

 

749

Total stock-based compensation expense

$

1,688

$

1,546

$

4,758

$

3,754

Schedule of option activity transactions

The following table summarizes stock option activity for the nine months ended September 30, 2025 (in thousands, except share and per share data):

    

    

    

Weighted- 

    

Number of 

Average 

Shares 

Weighted- 

Remaining 

Underlying 

Average 

Contractual 

Aggregate 

Outstanding 

Exercise 

Term 

Intrinsic 

Options

Price

(in Years)

Value (1)

Outstanding, January 1, 2025

 

4,462,517

$

6.58

 

7.4

$

619

Granted

 

1,276,597

4.83

 

 

Exercised

(44,792)

6.14

Forfeited/expired

 

(147)

23.05

 

 

Outstanding, September 30, 2025 (2)

 

5,694,175

$

6.19

 

7.3

$

7,048

Vested and expected to vest, September 30, 2025

 

5,694,175

$

6.19

 

7.3

$

7,048

Exercisable at September 30, 2025

 

3,422,341

$

6.74

 

6.3

$

2,668

(1)Aggregate intrinsic value represents the difference between the fair value of the Company’s Series A common stock on the last day of the fiscal period and the exercise price, multiplied by the number of options outstanding.
(2)Includes 477,467 performance-based options with a weighted-average exercise price of $6.44, all of which were fully vested and exercisable.
Schedule of restricted stock unit activity

Weighted-Average

    

Restricted

    

Grant Date

    

Stock Units

    

Fair Value

Outstanding, January 1, 2025

 

844,382

$

2.96

Granted

 

254,017

4.71

Vested/released

 

(281,462)

2.96

Outstanding, September 30, 2025

816,937

$

3.50

Schedule of fair value assumptions

    

Nine Months Ended September 30, 

2025

2024

Expected volatility

 

95 - 96

%  

91 - 96

%  

Risk-free interest rate

 

4.1 - 4.3

%  

3.9 - 4.5

%  

Dividend yield

 

 

 

Expected term (in years)

 

5.3 - 6.0

5.3 - 6.1